StonvexLoading…
StonvexStonvexStonvexCore line items from FUL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-02-28 | Annual 2025 2025-11-29 | Q3 2025 2025-08-30 | Q2 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $770.84M | $3.47B | $2.58B | $1.69B |
Operating Income | $27.55M | $215.42M | $256.63M | $146.49M |
Net Income | $21.05M | $151.97M | $122.24M | $55.08M |
EPS (Diluted) | $0.38 | $2.75 | $2.21 | $0.99 |
Total Assets | $5.22B | $5.18B | $5.17B | $5.13B |
Total Liabilities | $3.15B | $3.18B | $3.21B | $3.26B |
Cash & Equivalents | $107.88M | $107.21M | $122.46M | $96.78M |
Free Cash Flow OCF − CapEx | $-61.67M | $121.22M | $62.16M | $-6.76M |
Shares Outstanding | 54.48M | 54.17M | 54.04M | 53.95M |